Northwest Biothrputcs Inc
(NWBO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -21,545 | -73,143 | -46,144 | -22,873 | -12,620 |
| Depreciation Amortization | 2,841 | 2,362 | 1,299 | 787 | 429 |
| Accounts payable and accrued liabilities | N/A | 501 | N/A | N/A | N/A |
| Other Working Capital | 2,236 | 8,055 | 12,607 | 5,164 | -206 |
| Other Operating Activity | 11,681 | 25,730 | 10,537 | 946 | 114 |
| Operating Cash Flow | $-4,787 | $-36,495 | $-21,701 | $-15,976 | $-12,283 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -8 | -14 | -9 | N/A |
| Other Investing Activity | 0 | 220 | 220 | 220 | 218 |
| Investing Cash Flow | $N/A | $212 | $206 | $211 | $218 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 4,430 | 13,973 | 9,273 | 5,059 | 3,040 |
| Debt Repayment | -2,450 | -5,252 | -4,902 | -880 | -1,730 |
| Common Stock Issued | 1,611 | 13,407 | 13,074 | 7,720 | 7,431 |
| Other Financing Activity | 3,171 | 12,162 | 2,550 | 0 | -693 |
| Financing Cash Flow | $6,762 | $34,290 | $19,995 | $11,899 | $8,048 |
| Exchange Rate Effect | -1,894 | -4,761 | -4,320 | -2,983 | -622 |
| Beginning Cash Position | 117 | 6,871 | 6,871 | 6,871 | 6,871 |
| End Cash Position | 198 | 117 | 1,051 | 22 | 2,232 |
| Net Cash Flow | $81 | $-6,754 | $-5,820 | $-6,849 | $-4,639 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,787 | -36,495 | -21,701 | -15,976 | -12,283 |
| Capital Expenditure | N/A | -8 | -14 | -9 | N/A |
| Free Cash Flow | -4,787 | -36,503 | -21,715 | -15,985 | -12,283 |